Company: SNY
Filing Date: 2025-06-27
Form Type: 11-K
Source: 0001104659-25-063672
Chunk: 2

Company: Sanofi
Filing Date: 2025-06-27
Form: 11-K
Chunk 2
---
,
as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for
our opinion.

Supplemental Information

The supplemental information in the accompanying schedule of assets (held at end of year) as of December 31, 2024,has been subjected to audit
procedures performed in conjunction with the audit of the Plan’s financial statements. The supplemental information is the responsibility of the Plan’s management. Our audit procedures included determining whether the supplemental information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental information. In forming our opinion on the supplemental information, we evaluated whether the supplemental information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the supplemental information is fairly stated, in all material respects, in relation to the financial statements as a whole.

| /s/ Fischer Cunnane & Associates Ltd |

Fischer Cunnane & Associates Ltd

Certified Public Accountants

We have served as the Plan’s auditor since 2013.

West Chester, Pennsylvania

June 27, 2025

Sanofi Puerto Rico Group Savings Plan

Statements of Net Assets Available for Benefits

As of December 31, 2024 and 2023

| ASSETS                                                               
 Investments                                                          |     | 2024 |            |     | 2023 |            |
|:---------------------------------------------------------------------|:----|:-----|-----------:|:----|:-----|-----------:|
| Plan interest in the Sanofi U.S. Group Savings Master Trust (Note 3) |     | $    | 30,517,199 |     | $    | 29,869,948 |
| Cash – interest bearing                                              |     |      |     22,209 |     |      |      5,552 |
| Total investments                                                    |     |      | 30,539,408 |     |      | 29,875,500 |
| Receivables                                                          |     |      |            |     |      |            |
| Contributions receivable from participating employees                |     |      |      6,205 |     |      |      6,662 |
| Contributions receivable from employer                               |     |      |     43,149 |     |      |     53